
doi: 10.3205/15ebm041
Zielsetzung und Relevanz: Europäische Zusammenarbeit bei der Erstellung von Nutzenbewertungen (ins. bei Medizinprodukten und Arzneimitteln) wird immer wichtiger, da die Redundanzen (alle Länder machen dasselbe) offensichtlich sind und auch HTA-Ressourcen effizient eingesetzt werden müssen.[for full text, please go to the a.m. URL]
EbM zwischen Best Practice und inflationärem Gebrauch; 16. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin
ddc: 610, 610 Medical sciences; Medicine
ddc: 610, 610 Medical sciences; Medicine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
